The addition of a drug to a blood product intravenous line raises the question of physical and chemical compatibility of the drug with the blood and any preservatives or additives in the blood product.
Co-administration of drugs via a blood transfusion has been discouraged in New Zealand and elsewhere. The addition of a drug to a blood product intravenous line raises the question of physical and chemical compatibility of the drug with the blood and any preservatives or additives in the blood product.
The addition of drugs to blood products may be necessary in operating theatres, in intensive care units, on general wards and in emergency departments. This clinical scenario is encountered frequently, for example when patients receiving opioids as intravenous patient-controlled analgesia (PCA) require blood transfusions, or when patients receiving an emergency blood transfusion require intravenous analgesia. Does one need separate intravenous access or can one add the drugs to the blood product line directly?
The direct addition of drugs to blood products has not been well studied. There are very few published articles that discuss potential compatibility of drugs co-infused with blood. In our literature search we found no formal compatibility studies. The American Association of Blood Banks identifies only normal sodium chloride as an appropriate solution for use in one limb of a "Y" infusion set to aid in the transfusion of blood products 1 .
The limited literature available alludes to problems associated with mixing of dextrose solutions and lactated Ringer's solutions with blood products 2,3 . The red blood cell (RBC) product transfused in our institution is a standard red cell concentrate known in New Zealand as resuspended red blood cells (RRBC). The addition of drugs to the RRBC cannot be considered directly analogous to the addition of drugs to whole blood in vivo. The biochemical changes that occur in the RRBC with time include changes in pH, haematocrit levels, 2,3 DPG levels, potassium concentration, and sodium concentration 1, 4 . There are therefore several variables that may influence the stability of the drugs after addition to RRBC.
It would be useful clinically to ascertain whether it is feasible to co-infuse specific drugs and RRBC, with respect to the stability of the blood products and those drugs 5 . The concerns regarding co-infusion of drugs and blood products are theoretically justified. However, these concerns are not based on evidence and this study was designed to provide this.
MATERIALS AND METHODS
The study consisted of two main parts: the first part involved ascertaining what happened to RRBC after the addition of drugs that are commonly used in our hospital for postoperative intravenous analgesia. The second part of the study determined the effect of RRBC on drug concentrations.
Part 1
Morphine 1 mg/ml, pethidine 10 mg/ml and ketamine 1 mg/ml were prepared by the hospital pharmacy using normal saline as the diluent. These are the concentrations that are commonly used for PCA in our hospital. Each drug sample (1 ml) was added to 10 ml of RRBC. This volume was chosen as it approximates the volume of the intravenous infusion "giving sets" that are used in our hospital (6 to 13 ml). This would therefore represent the amount of RRBC that the drug would be mixed with initially if co-infusion were to occur. Normal saline 1 ml was added to 10 ml of RRBC to serve as the control sample.
The drugs/RRBC samples were then sent to the laboratory for quality control tests. Three samples of each mixture were prepared and the laboratory performed tests on all the samples. The laboratory was blinded to whether normal saline or drug had been added to the samples. At our institution the potassium concentration is an important quality control test for RRBC as this is indicative of the degree of haemolysis of the RBC.
The Blood Transfusion Service Haematologist reported the red cell morphology on all samples using standard May Grunwald-Giemsa staining. The haematologist was blinded to which samples had drugs added. Grading was performed for anisopoikilocytosis, microangiopathy, spherocytosis and rouleaux. The RRBC samples were graded as follows: 0 = nil, 1+ = mild, 2+ = moderate, 3+ = marked. The above process was carried out on RRBC/drug mixtures at different stages of RRBC storage: 3 days old, 8 days old, 21 days old and 30 days old. This was done to eliminate any incompatibilities that might arise due to the biochemical changes that occur in stored blood as it ages.
The mean red cell distribution width of the samples was measured to further quantify the degree of anisocytosis.
Part 2
Morphine 1 mg/ml, pethidine 10 mg/ml and ketamine 1 mg/ml were prepared by the hospital pharmacy using normal saline as the diluent. These drugs were then incubated with RRBC at the same concentrations as in part 1. The drug concentrations were measured immediately after mixing with the RRBC sample (0 minutes) and again at 20 minutes. The time that the drug would be in contact with RRBC before being infused into the patient would normally be considerably less than 20 minutes. Two groups of RRBC were used, at three days storage and at 30 days. The supernatant serum was aspirated off the cells after centrifugation. The concentration of the drugs was determined by reverse phase high performance liquid chromatography (HPLC) after extraction on strong cation exchange (SCX) solid phase extraction columns as per the method of Logan et al 5 . The measurements were performed in triplicate.
Statistics
Analysis was performed on potassium, mean cell distribution width, and drug concentrations using Analysis of Variance (ANOVA), and Student's t tests where appropriate.
RESULTS

Part 1
The samples of RRBC were all passed by quality control. No sample had a potassium concentration that was deemed unacceptable. The addition of drugs to the RRBC was associated with lowered concentrations of potassium in some instances. (Table 1 ). An ANOVA test was performed which showed that there was no significant difference in potassium concentration between the samples (P=0.07) at 3, 8, 21 and 30 days.
The addition of drugs to RRBCs did not affect the morphology of the cells in suspension, in that all samples were graded 1+ for anisopoikilocytosis, 0 for microangiopathy, 3+ for spherocytosis and 0 for rouleaux. These results were not clinically significant, the grading being compatible with normal stored RRBC. The mean red cell widths are shown in Table  2 . There was no difference in red cell diameter between the groups (P=0.31) on ANOVA testing.
Part 2
The results of the drug measurements are shown in Table 3 .
These results show that there is no decrease in drug concentration after mixing with RRBC for 20 minutes. On statistical analysis (paired Student's t test) there was no difference between the concentrations of morphine at 0 and 20 minutes in the threeday sample (P=0.5), and the 30-day-old sample (P=0.12). Similarly there was no difference between the ketamine at 0 and 20 minutes in the three-day-old sample (P=0.23) and the 30-day-old sample (P=0.26). The pethidine showed no difference in the 30-day-old sample (P=0.22) but there was a difference in the three day old sample. (P=0.01).
DISCUSSION
The findings in this study show that co-infusion of morphine, pethidine and ketamine in 0.9% saline with RRBC is not detrimental to the integrity of the RRBC. We also show that the mixture of the drugs with RRBC does not decrease the drug concentration after 20 minutes.
Co-infusion of these drugs with RRBC is beneficial in many clinical situations. Patients commonly receive these drugs as PCA for postoperative analgesia. These patients also require RRBC postoperatively from time to time. In the past this has meant either stopping the PCA for the duration of the RRBC infusion, or inserting another intravenous catheter. This is inconvenient and uncomfortable for the patient and labour intensive for medical and nursing staff. It also adds unnecessary costs for the patient and the hospital.
Other instances where co-infusion would be bene-ficial would occur in the operating theatre, intensive care ward and emergency department where RRBC transfusions are given urgently in association with blood loss and where simultaneous administration of intravenous analgesia may be warranted. Anaesthetists and other clinicians not infrequently are faced with this scenario. In the past, clinicians have co-infused drugs and blood, either in desperation or in ignorance. There have been no case reports of any detrimental effects associated with this practice. The primary concern with the practice of coinfusion has been that the drug or drugs would harm the RRBC resulting in haemolysis, clumping of cells, and changes in the biochemistry (e.g., potassium) 4 . This was shown not to happen, both by the morphological assessment by a haematologist, and by the other quality control tests performed at our institution and reported here. The morphology of the red cells in RRBC is unchanged by the addition of these drugs at any stage during storage and the mean RBC distribution width in the samples remains constant after the addition of drugs.
The drug concentrations measured at 0 minutes and again at 20 minutes demonstrate that there is no significant loss of free drug in the RRBC serum. This refutes the concerns that the drug may be absorbed from the plasma into the RBC, or that it is bound to the RBC in any significant proportion. It was thought that the drug may be absorbed into the cells or that it may bind to the cells and therefore the bioavailability would decrease. The levels for morphine and ketamine at 0 and 20 minutes are practically identical. One surprising aspect of the pethidine results for three-day-old RRBC is that the concentration increased after 20 minutes. There are areas where measurement error may occur, e.g., with the extraction process. The increase in pethidine concentration may be due to its different pharmacokinetic properties, such as increased protein binding and increased lipid solubility, which may interfere with its measurement 6 . However, while this increase is statistically significant, it would not be clinically significant as the difference in concentration is a very small percentage of the intended dose. Importantly there is no decrease in drug concentration over time and therefore patients receiving analgesia would receive the intended dose of analgesia.
This study does not address the risk of infection associated with co-infusion. It must be stressed that blood products are a potential culture medium for microorganisms and therefore any substance added to blood should be added in a strictly aseptic manner. In conclusion this study demonstrates that the concern regarding injury to red cells in standard red cell concentrates by these drugs is unjustified. Morphine, pethidine and ketamine mixed in normal saline did not adversely affect the RRBC in any manner that was measurable or observed. Similarly, drug concentrations were not decreased after mixing with RRBC. We suggest that health authorities review this clinical issue in their transfusion guidelines. Our findings suggest that co-infusion would not be deleterious. We have shown that the concerns discouraging coadministration of these drugs via a blood transfusion are not founded.
